APA (7th ed.) Citation

Tsubaki, M., Matsuo, T., Komori, R., Nagai, N., Yamamoto, T., & Nishida, S. (2025). HSP90 inhibitors promote cell death by degrading Met and BCR: :ABL1 in both imatinib-resistant and -sensitive chronic myeloid leukemia cells. Future Journal of Pharmaceutical Sciences, 11(1), 1. https://doi.org/10.1186/s43094-025-00767-w

Chicago Style (17th ed.) Citation

Tsubaki, Masanobu, Taira Matsuo, Rie Komori, Noriaki Nagai, Tetsushi Yamamoto, and Shozo Nishida. "HSP90 Inhibitors Promote Cell Death by Degrading Met and BCR: :ABL1 in Both Imatinib-resistant and -sensitive Chronic Myeloid Leukemia Cells." Future Journal of Pharmaceutical Sciences 11, no. 1 (2025): 1. https://doi.org/10.1186/s43094-025-00767-w.

MLA (9th ed.) Citation

Tsubaki, Masanobu, et al. "HSP90 Inhibitors Promote Cell Death by Degrading Met and BCR: :ABL1 in Both Imatinib-resistant and -sensitive Chronic Myeloid Leukemia Cells." Future Journal of Pharmaceutical Sciences, vol. 11, no. 1, 2025, p. 1, https://doi.org/10.1186/s43094-025-00767-w.